Implications of detecting serum monoclonal protein by MASS‐fix following stem cell transplantation in multiple myeloma
Jithma P. Abeykoon(Mayo Clinic), Prashant Kapoor, Francis K. Buadi, Morie A. Gertz(Medical University of South Carolina), Nelson Leung(WinnMed), Isaiah Murray(Mayo Clinic in Arizona), Dragan Jevremović(Mayo Clinic in Arizona), Robert A. Kyle(Mayo Clinic), Shaji Kumar(Mayo Clinic), Ronald S. Go(Mayo Clinic), David Murray(Unknown), Rahma Warsame, Gregory E. Otteson(Mayo Clinic in Arizona), Surendra Dasari(Mayo Clinic in Arizona), S. Vincent Rajkumar(WinnMed), Wilson I. Gonsalves(Mayo Clinic in Arizona), Taxiarchis Kourelis(Mayo Clinic in Arizona), Martha Q. Lacy(Mayo Clinic), Eli Muchtar(Mayo Clinic), Yi Lin, Angela Dispenzieri(Mayo Clinic), Bonnie K. Arendt(Mayo Clinic), David Dingli
Cited by 30
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k